Clinical Trial Associate, Clinical Operations

United States

Apply with AI Apply

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, Clinical ResearchIndustries

Requirements

Candidates must have a Bachelor's degree, preferably in a life sciences or related field, and a minimum of 1-2 years of clinical trial experience. They should be independent professionals who communicate effectively and proactively, possess strong organizational skills to manage multiple projects with tight deadlines, and demonstrate a high energy level, positive attitude, and the ability to work well under stress. Assertiveness and effective communication are also key qualifications, along with a hands-on, action-oriented approach.

Responsibilities

The Clinical Trials Associate will provide project system, tracking, and administrative support to the study team throughout all phases of clinical study activities, including feasibility, start-up, maintenance, and close-out. Key duties include maintaining the Trial Master File (TMF) in compliance with ICH-GCP and company SOPs, managing study team SharePoint sites and databases, tracking essential study and site documents, and supporting vendor and site contract tracking. The role also involves organizing and managing study execution team meetings, communicating effectively with stakeholders, participating in internal audits and inspection readiness activities, and attending teleconference calls and meetings as requested, with up to 10% travel required.

Skills

Clinical Trial Management

Trial Master File (TMF)

ICH-GCP

SharePoint

Document Management

Data Entry

Vendor Management

Site Management

Contract Management

Project Support

Administrative Support

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free